If You Vanda Patent a Genetic Test, Induce the Doctor to Infringe

As summer vacations end, school for kids and big kids starts up, and we return to the reality that is September, we present a little...

Celebrating 15 Years of Teaching: Chemical and Biotech Patent Practice

Directors Harry Shubin and Brion Heaney Celebrate the completion of their 15th year of teaching “Chemical and Biotech Patent Practice” at George Mason University’s Antonin...

New Fixed Fee Design Product

We are pleased to announce a new Fixed Fee structure for filing and prosecuting Design patent applications. This new fixed fee product is aimed at...

Case Studies – Hidden Gems for Applicants Regarding Obviousness and Anticipation

The Federal Circuit is holding the USPTO to its burden of establishing anticipation and obviousness, and requiring it to support such rejections by adequate reasoned...

Millen, White, Zelano & Branigan, P.C. Announces Promotion of Attorney to Partner for 2018

Arlington, Virginia, and Austin, Texas — Millen, White, Zelano & Branigan, P.C. is pleased to announce the election of Adam Mandell to partner, effective January 1,...

Dr. Larry Millstein, a MWZB Director, was unanimously re-elected to serve a third term as President of PSW Science.

Dr. Larry Millstein, a MWZB Director, was unanimously re-elected to serve a third term as President of PSW Science. PSW was founded in 1871 by...

MWZB Scores Big at the Federal Circuit

Mike Culver, with the help of Richard Traverso and Csaba Henter on the briefs, successfully persuaded the Federal Circuit to unanimously affirm the PTAB’s (the...

USPTO’s IPR Practice Detrimental to Patentees Found Erroneous by En Banc Federal Circuit Court

The Inter Partes Review (IPR) practice of the USPTO’s Patent Trial and Appeal Board (the Board) has been largely viewed as one-side against patentees. Since...
1 2 3 4 10

Categories

Archive

MWZB Newsletter Signup

Subscribe
Confidential/Privileged Information MWZB is pleased that you would like to contact the firm. However, you should be aware that any information, documents and the like submitted in connection with this email message or otherwise via the firm’s website will not be treated as a privileged or confidential attorney/client communication unless and until the relationship is governed by an engagement letter. You are not a client of MWZB in the absence of such an engagement letter. If you understand and accept these terms and wish to proceed, please enter your email address below.

Newsletter Signup